Before founding Gulf Sterilization, Michelle Scott built a well-respected speech pathology private practice, which continues to thrive today, 15 years later. During and after the pandemic, she became increasingly aware of medical product supply chain challenges through conversations with colleagues and family in the healthcare industry. Her research revealed a critical issue: limited sterilization capacity, increased turnaround times, and growing concerns over the environmental and safety risks associated with traditional sterilization methods. Determined to provide a safer, more sustainable solution, Scott established Gulf Sterilization—a state-of-the-art facility specializing in chlorine dioxide (CD) gas sterilization. As CEO, she led the company through the rigorous ISO 13485 certification process and continues to drive innovation in CD technology, including process optimization and packaging development. Most recently, she was named one of Alabama’s top 25 women in Bio Tech for 2025. An active leader in the sterilization industry, Scott serves as a member of Bio Alabama, Florida Medical Manufacturers Consortium, Parenteral Drug Association, Women in Bio, Kilmer Modalities Team, the Biotechnician Task Force for ACCS Innovation Center and the Advancing Sight Network Innovation committee. She also contributes to the Industrial Sterilization and Sterile Processing Working Groups and is currently drafting TIR124: Guidance Document on CD Sterilization for the Association for the Advancement of Medical Instrumentation (AAMI).